ReviewThe American journal of case reports2026
Laparoscopic-Assisted Microwave Ablation for Splenic Hemangioma: A Case Report and Literature Review.
Review in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Hemangioma is the most common benign primary tumor of the spleen and is often detected incidentally. Laparoscopic-assisted microwave ablation (LMWA) has recently been introduced as a novel approach for managing splenic hemangioma. This report describes the case of a 67-year-old woman with an asymptomatic, progressively enlarging splenic hemangioma successfully treated with LMWA. CASE REPORT A 67-year-old woman was admitted for evaluation of a gradually enlarging splenic mass found during routine examination. She was asymptomatic, with normal tumor markers and a mildly elevated D-dimer level. Contrast-enhanced CT revealed a 6.0 cm hypervascular lesion in the upper pole of the spleen. After multidisciplinary discussion, LMWA was performed under direct laparoscopic visualization. The lesion was completely ablated, with a total operative time of 80 minutes, including 25 minutes of ablation. Estimated blood loss was minimal (20 mL). Postoperative pathology examination confirmed a splenic cavernous hemangioma. The postoperative course was uneventful, and she was discharged on day 5. Follow-up imaging showed reduction of the ablation zone to 5.4 cm, and laboratory results returned to normal. CONCLUSIONS This is the first report on the feasibility and safety of LMWA for treating splenic hemangioma. This approach effectively reduces intraoperative bleeding and postoperative hemolysis while preserving splenic function, offering a novel treatment option for splenic hemangioma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.